Bile Acid Sequestrants

Verified · Oct 2026

Prototype: cholestyramine

Bile Acid Sequestrants are a class of medications used for primary hypercholesterolemia.

Medical view → mechanisms, drug comparisons and Step 1 pharmacology

Cholestyramine, colestipol and colesevelam stay in the gut and lower LDL cholesterol indirectly. Because they bind bile acids, they also bind other drugs and fat-soluble vitamins — timing doses is the core nursing skill.

How it works in the body

The system involved, what goes wrong, and how the drug and body interact.

01 Breaking the enterohepatic cycle

Cholesterol is the main precursor of bile acids. Bile acids are secreted into the intestine, help absorb dietary fat, and most are reabsorbed and returned to the liver — the enterohepatic circulation.

Bile acid sequestrants bind bile acids in the intestine into an insoluble complex that leaves in the feces. To replace them, the liver converts more cholesterol into bile acids (cholesterol 7-α-hydroxylase is upregulated), which increases the number of hepatic LDL receptors and clears more LDL from the blood. The liver also makes more cholesterol, yet serum cholesterol still falls — and triglycerides may rise or stay the same.

Loading diagram…

Trapping bile acids makes the liver use cholesterol and pull LDL from the blood.

02 Why a drug that is never absorbed still needs careful handling

The resins are not absorbed, so their problems are local. Constipation is the most common adverse effect and can progress to fecal impaction or bowel obstruction. Because they bind bile acids, they interfere with fat absorption and can cause deficiencies of the fat-soluble vitamins A, D, E and K; vitamin K deficiency can cause a bleeding tendency.

They also bind many other oral drugs — thyroid hormone, warfarin, digoxin, thiazides, phenytoin and more — so other medicines are timed well apart from the resin. Cholestyramine and colestipol are chloride-form anion-exchange resins, and prolonged use can cause hyperchloremic acidosis. Colesevelam can raise triglycerides, and very high triglycerides can cause acute pancreatitis.

Drug names

Generic Brand

cholestyramine Prevalite

colestipol Colestid

colesevelam —

Indications

Primary hypercholesterolemia (elevated LDL-C) — with diet, alone or with a statin
Colesevelam for heterozygous familial hypercholesterolemia in boys and postmenarchal girls aged 10 to 17
Colesevelam to improve glycemic control in adults with type 2 diabetes
Cholestyramine for pruritus from partial biliary obstruction

Mechanism of action

Non-absorbed resins (polymers) that bind bile acids in the intestine into an insoluble complex excreted in the feces, interrupting the enterohepatic circulation. The liver upregulates cholesterol 7-α-hydroxylase to convert more cholesterol into bile acids, increasing hepatic LDL receptors and LDL clearance, so serum LDL-C falls despite increased hepatic cholesterol synthesis. How colesevelam improves glycemic control is unknown.

In plain terms

They soak up bile acids in the gut so the liver has to use its cholesterol to make more, pulling LDL cholesterol out of the blood.

Therapeutic effects — what you'll see working

Success is a lower LDL cholesterol on a repeat lipid panel — the effect appears within weeks — with triglycerides kept in check and constipation managed.

↓ LDL cholesterol Lower A1c (colesevelam) Less itching (cholestyramine)

↓ LDL cholesterol: More hepatic LDL receptors clear LDL from the blood; a maximum lipid response to colesevelam was reached within 2 weeks, and with colestipol the fall is usually evident by one month and reverses within a month of stopping.
Lower A1c (colesevelam): In type 2 diabetes, an HbA1c reduction was first seen after 4–6 weeks and reached its maximum after 12–18 weeks; the mechanism is unknown.
Less itching (cholestyramine): In partial biliary obstruction, lowering serum bile acids reduces bile acids deposited in the skin, easing pruritus.

Adverse effects

Problems stay in the gut but spread through what the resin binds: constipation, missing vitamins, other drugs that stop working — and, with colesevelam, triglycerides.

Common

Constipation, abdominal discomfort, bloating and flatulence, nausea, dyspepsia.

Constipation is the most common adverse reaction; higher doses and age over 60 predispose to it with cholestyramine, and most cases are mild and transient. Increasing fluid and fiber intake comes first, and a stool softener is occasionally needed.

Serious — bowel or esophageal obstruction Hold & notify

Fecal impaction or bowel obstruction, and esophageal obstruction from the large tablets.

The resins can produce or severely worsen constipation, so doses are increased gradually. Bowel obstruction has occurred with colesevelam, which is not recommended with gastroparesis, other motility disorders or major GI surgery; rare intestinal obstruction (including two deaths) has been reported in children taking cholestyramine. Severe abdominal pain or severe constipation means stopping colesevelam and seeking care.

Colesevelam · hypertriglyceridemia and pancreatitis Hold & notify

Colesevelam can raise triglycerides, and hypertriglyceridemia can cause acute pancreatitis.

Triglycerides are checked before starting and periodically; patients with levels above 300 mg/dL may need extra monitoring, and colesevelam is stopped if they exceed 500 mg/dL. Severe abdominal pain with or without nausea and vomiting may be pancreatitis.

Vitamin deficiency and bleeding Hold & notify

Reduced absorption of vitamins A, D, E and K and folate, with a bleeding tendency from vitamin K deficiency.

Chronic use can cause hypoprothrombinemia from vitamin K deficiency, which usually responds promptly to parenteral vitamin K; patients on warfarin or with malabsorption are at greater risk. Long-term cholestyramine may need supplementation with water-miscible or parenteral fat-soluble vitamins, and folic acid if folate falls.

Cholestyramine, colestipol · hyperchloremic acidosis

Prolonged use of these chloride-form resins may cause hyperchloremic acidosis.

The risk is greatest in younger and smaller patients; caution is advised with renal insufficiency, volume depletion or concomitant spironolactone.

Interactions

Other oral drugs (e.g., thyroid hormone, warfarin, digoxin, thiazides, propranolol, tetracycline, penicillin G, estrogens and progestins) drug

The resin can delay or reduce their absorption. Give other drugs at least 1 hour before or 4–6 hours after cholestyramine, 1 hour before or 4 hours after colestipol, and at least 4 hours before colesevelam.

Colesevelam + levothyroxine, phenytoin, cyclosporine, warfarin, oral contraceptives, olmesartan, glyburide, glipizide, glimepiride drug

Lower exposure of these drugs — give them 4 hours before colesevelam. Reported effects include raised TSH, more seizures or lower phenytoin levels, and a reduced INR.

Colesevelam + metformin extended-release drug

Colesevelam may increase metformin ER exposure — monitor glycemic control.

Digitalis (digoxin) — when cholestyramine is stopped drug

Stopping cholestyramine could pose a hazard if digitalis was titrated while the patient was taking it.

Fat-soluble vitamins (A, D, E, K) and folic acid food

Absorption is reduced — take oral vitamins at least 4 hours before colesevelam; long-term cholestyramine may need water-miscible or parenteral forms.

Statins drug

Preliminary evidence suggests the LDL-lowering effects add up — enhanced with cholestyramine, additive with colestipol (studied with lovastatin); colesevelam can be taken at the same time as a statin or apart.

Contraindications

Each label has its own short list: an obstructed biliary tree for cholestyramine, high triglycerides and bowel obstruction for colesevelam, and hypersensitivity.

Cholestyramine: complete biliary obstruction (no bile reaching the intestine)

Labeled contraindication: in complete biliary obstruction, bile is not secreted into the intestine.

Colesevelam: serum triglycerides > 500 mg/dL, or a history of hypertriglyceridemia-induced pancreatitis

Colesevelam can raise triglycerides, and hypertriglyceridemia can cause acute pancreatitis.

Colesevelam: history of bowel obstruction

Postmarketing bowel obstruction has occurred with colesevelam.

Cholestyramine, colestipol: hypersensitivity to any component

Listed as a contraindication on both labels.

Gastroparesis, other GI motility disorders, major GI surgery, or pre-existing constipation use caution

Constipating effects can lead to impaction or bowel obstruction (colesevelam is not recommended in motility disorders or after major GI surgery).

Difficulty swallowing (colesevelam and colestipol tablets) use caution

The large tablets can cause dysphagia or esophageal obstruction; colesevelam oral suspension is the alternative.

Phenylketonuria (Prevalite) use caution

Prevalite contains phenylalanine.

When to hold

Assess before giving — these findings mean hold the dose and act.

Colesevelam — triglycerides above 500 mg/dL

Hold and notify — the label says to discontinue colesevelam.

Severe abdominal pain, severe constipation, or symptoms of pancreatitis

Hold and notify — possible bowel obstruction or pancreatitis (colesevelam label: discontinue and seek prompt care).

A tablet sticks in the throat or swallowing becomes difficult

Do not give the next tablet; notify the prescriber (Colestid: do not take again without advice).

Labs & levels

Test Therapeutic / normal Toxic / critical

Lipid panel (LDL-C, triglycerides) Baseline including triglycerides; colesevelam within 4–6 weeks of starting; cholestyramine frequently in the first months, then periodically. — Colesevelam: triglycerides > 500 mg/dL → stop; > 300 mg/dL → closer monitoring

INR (patients on warfarin) With colesevelam, frequently during initiation and then periodically. — —

Nursing considerations

The RN-specific layer — each action paired with the reason it matters.

Before starting (all three)

Obtain a baseline lipid panel including triglycerides, and ask about constipation, bowel obstruction, swallowing problems and phenylketonuria.

Why: Colesevelam is contraindicated with triglycerides above 500 mg/dL or a history of bowel obstruction; constipation can worsen, the tablets are large, and Prevalite contains phenylalanine.

Review every other oral medication and build a dosing schedule that separates them from the resin.

Why: The resins bind other drugs and reduce their absorption.

Cholestyramine (powder)

Never give the powder dry. Mix each dose in at least 2–3 ounces of water or another beverage (or a fluid soup or pulpy fruit such as applesauce) and stir well.

Why: The label requires mixing with fluid before swallowing.

Discourage sipping or holding the suspension in the mouth; encourage good oral hygiene.

Why: Prolonged contact can discolor teeth, erode enamel or cause decay.

Give other drugs at least 1 hour before or 4–6 hours after cholestyramine.

Why: Cholestyramine can bind drugs given at the same time.

Colestipol (tablets, granules)

Tablets: give one at a time, swallowed whole with plenty of water or other liquid — not cut, crushed or chewed. Granules: never dry; mix in at least 3 ounces of liquid and rinse the glass.

Why: Large tablets can stick, and the dry granules can be inhaled or cause esophageal distress.

Give other drugs at least 1 hour before or 4 hours after colestipol.

Why: Colestipol binds a number of drugs and may delay or reduce their absorption.

Colesevelam (tablets)

Give with a meal and liquid; use the oral suspension for patients who have trouble swallowing tablets and for children.

Why: The tablets are large and can cause dysphagia or esophageal obstruction.

Give levothyroxine, phenytoin, cyclosporine, oral contraceptives, olmesartan, sulfonylureas and vitamins at least 4 hours before colesevelam; check the INR more often in patients on warfarin.

Why: Colesevelam lowers the absorption of these drugs; a reduced INR has been reported with warfarin.

Recheck lipids within 4–6 weeks, including triglycerides.

Why: Colesevelam can raise triglycerides; it is stopped above 500 mg/dL.

Patient teaching

Drink plenty of fluids and increase fiber; report severe abdominal pain or severe constipation right away.

Why: Constipation is common and can progress to impaction or bowel obstruction.

Report unusual bleeding or bruising.

Why: Chronic use can cause a bleeding tendency from vitamin K deficiency.

Tell the prescriber before stopping cholestyramine if you take digoxin.

Why: Stopping cholestyramine could pose a hazard if digitalis was titrated to a maintenance level while taking it.

Common questions

What are Bile Acid Sequestrants used for?

Bile Acid Sequestrants are used for primary hypercholesterolemia. Colesevelam for heterozygous familial hypercholesterolemia in boys and postmenarchal girls aged 10 to 17. Colesevelam to improve glycemic control in adults with type 2 diabetes. Cholestyramine for pruritus from partial biliary obstruction.

How do Bile Acid Sequestrants work?

They soak up bile acids in the gut so the liver has to use its cholesterol to make more, pulling LDL cholesterol out of the blood.

What are the serious side effects of Bile Acid Sequestrants?

Watch for fecal impaction or bowel obstruction, and esophageal obstruction from the large tablets; colesevelam can raise triglycerides, and hypertriglyceridemia can cause acute pancreatitis; reduced absorption of vitamins A, D, E and K and folate, with a bleeding tendency from vitamin K deficiency.

When should a nurse hold Bile Acid Sequestrants, and what safety checks apply?

Colesevelam — triglycerides above 500 mg/dL: hold and notify — the label says to discontinue colesevelam. Severe abdominal pain, severe constipation, or symptoms of pancreatitis: hold and notify — possible bowel obstruction or pancreatitis (colesevelam label: discontinue and seek prompt care). A tablet sticks in the throat or swallowing becomes difficult: do not give the next tablet; notify the prescriber (Colestid: do not take again without advice).

What labs should be monitored with Bile Acid Sequestrants?

Monitor lipid panel (LDL-C, triglycerides) and INR (patients on warfarin).

Sources

Reviewed by Hae Suk Lee, RN

Educational summary for nursing students. Always verify against current prescribing information and your institution's protocols before administering. Not medical advice.